PROViatris Inc
stock17.54
-0.10 (-0.57%)
Price as of 13 Oct, 19:51 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Attractive
Attractive investment profile
Technical Analysis
Short-Term Outlook
Bearish
0 bull · 3 bear · 2 neutral
Medium-Term Outlook
Neutral
2 bull · 2 bear · 0 neutral
Price above 50-day MA
Price above 200-day MA
Price below 12-day EMA
Price below 26-day EMA
Neutral momentum zone
MACD below signal line
%K below %D
Price near middle band
Volatility measure — informational only
Volume Indicators
On Balance Volume (OBV)
Volume Accumulation Distribution (VAD)
Market Statistics
Day Change
-0.10
Market Cap
20135117000
Exchange
NASDAQ
Sector
Health Care
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Fundamental Analysis
Unable to load fundamental data
Learn about Viatris Inc
What is Viatris Inc?
Viatris Inc is a global healthcare company formed by the merger of Mylan and Upjohn, focusing primarily on providing affordable, high-quality generic and branded medicines. It operates a vast portfolio of products across various therapeutic areas, including cardiovascular, oncology, and infectious disease, reaching patients in more than 165 countries. The company aims to increase access to essential treatments while leveraging its large-scale manufacturing and distribution capabilities.
Is Viatris Inc a good investment?
Viatris offers potential value through its strong cash flow and stable dividend yield, which can be attractive for income-focused portfolios. However, investors must consider the challenges of high debt levels, ongoing product pipeline integration, and intense competition in the generic drug market. Please note that this information is for educational purposes only and does not constitute professional financial advice.
How do you invest in Viatris Inc?
You can invest in Viatris by purchasing shares directly through a brokerage account using its ticker symbol VTRS on the NASDAQ stock exchange. Alternatively, you may gain exposure by investing in healthcare-focused ETFs or mutual funds that include Viatris among their holdings. Ensure you research your preferred platform's fees and account minimums before placing your trade.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for VTRS — be the first to start the discussion.
Point & Figure Analysis
OHLC
Signals
as of 09 Oct 2026Targets
No active targets — trend is consolidating.
Famous Investors Holding VTRS
Ray Dalio
1.70M sh · 0.1% of portfolio
$26.97M
NEW
Ken Griffin
661.0K sh · 0.0% of portfolio
$10.50M
NEW
Ken Griffin
502.3K sh · 0.0% of portfolio
$7.98M
NEW
Ken Griffin
241.8K sh · 0.0% of portfolio
$3.84M
NEW
Mario Gabelli
177.0K sh · 0.0% of portfolio
$2.81M
NEW
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.